NO300488B1 - Neurologisk behandlingsanordning - Google Patents

Neurologisk behandlingsanordning Download PDF

Info

Publication number
NO300488B1
NO300488B1 NO915074A NO915074A NO300488B1 NO 300488 B1 NO300488 B1 NO 300488B1 NO 915074 A NO915074 A NO 915074A NO 915074 A NO915074 A NO 915074A NO 300488 B1 NO300488 B1 NO 300488B1
Authority
NO
Norway
Prior art keywords
neurotransmitter
growth factor
dopamine
cell
insert material
Prior art date
Application number
NO915074A
Other languages
English (en)
Norwegian (no)
Other versions
NO915074L (no
NO915074D0 (no
Inventor
Patrick Aebischer
Shelley R Winn
Original Assignee
Univ Brown Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found filed Critical Univ Brown Res Found
Publication of NO915074D0 publication Critical patent/NO915074D0/no
Publication of NO915074L publication Critical patent/NO915074L/no
Publication of NO300488B1 publication Critical patent/NO300488B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0687—Skull, cranium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0693—Brain, cerebrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Massaging Devices (AREA)
  • Saccharide Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO915074A 1989-06-21 1991-12-20 Neurologisk behandlingsanordning NO300488B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36929689A 1989-06-21 1989-06-21
PCT/US1990/003492 WO1990015637A2 (fr) 1989-06-21 1990-06-20 Systeme de therapie neurologique

Publications (3)

Publication Number Publication Date
NO915074D0 NO915074D0 (no) 1991-12-20
NO915074L NO915074L (no) 1992-01-31
NO300488B1 true NO300488B1 (no) 1997-06-09

Family

ID=23454885

Family Applications (1)

Application Number Title Priority Date Filing Date
NO915074A NO300488B1 (no) 1989-06-21 1991-12-20 Neurologisk behandlingsanordning

Country Status (12)

Country Link
EP (1) EP0478671B1 (fr)
JP (1) JP2738881B2 (fr)
KR (1) KR0141583B1 (fr)
AT (1) ATE89485T1 (fr)
AU (1) AU632827B2 (fr)
CA (1) CA2062746C (fr)
DE (1) DE69001672T2 (fr)
DK (1) DK0478671T3 (fr)
ES (1) ES2058923T3 (fr)
FI (1) FI916066A0 (fr)
NO (1) NO300488B1 (fr)
WO (1) WO1990015637A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773286A (en) * 1987-11-17 1998-06-30 Cytotherapeutics, Inc. Inner supported biocompatible cell capsules
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
US5871472A (en) * 1987-11-17 1999-02-16 Brown University Research Foundation Planting devices for the focal release of neuroinhibitory compounds
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
EP0528978B1 (fr) * 1990-05-16 2002-10-16 Southern Research Institute Mikrocapsules pour liberation regulee et son utilisation pour stimuler la croissance de fibres nerveuses
CA2103705C (fr) * 1991-02-11 1996-01-30 Ayub K. Ommaya Organe artificiel a liquide cephalo-rachidien
SG47470A1 (en) * 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
US5800829A (en) * 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
DK0550719T3 (da) * 1991-06-28 1997-09-01 Univ Brown Res Found Neutralt implanteringssystem
WO1993000128A1 (fr) * 1991-06-28 1993-01-07 Brown University Research Foundation Dispositif d'implant neuronal renouvelable et procede d'utilisation
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
WO1994015663A1 (fr) * 1992-12-30 1994-07-21 Brown University Research Foundation Procedes therapeutiques et systemes therapeutiques implantables
AU678843B2 (en) * 1993-08-10 1997-06-12 W.L. Gore & Associates, Inc. Cell encapsulating device
WO1997010807A1 (fr) * 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Dispositif ameliore d'encapsulation de cellules
US6110707A (en) * 1996-01-19 2000-08-29 Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
US6087129A (en) 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
US6322962B1 (en) 1998-08-14 2001-11-27 Board Of Regents, The University Of Texas System Sterol-regulated Site-1 protease and assays of modulators thereof
ES2353728T3 (es) 1999-02-10 2011-03-04 Curis, Inc. Péptido yy (pyy) para tratar trastornos metabólicos de la glucosa.
US7745216B2 (en) 1999-02-10 2010-06-29 Curis, Inc. Methods and reagents for treating glucose metabolic disorders
AU2002230843B8 (en) 2000-12-14 2007-05-17 Amylin Pharmaceuticals, Llc Peptide YY and peptide YY agonists for treatment of metabolic disorders
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
PT2561860T (pt) 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
CA2520613C (fr) 2003-03-31 2012-12-04 Titan Pharmaceuticals, Inc. Dispositif polymere implantable pour liberation prolongee d'agoniste de la dopamine
WO2004110400A2 (fr) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Dispositif polymere implantable pour la liberation prolongee de nalmefene
JP5638177B2 (ja) 2004-02-11 2014-12-10 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
JP2010252924A (ja) * 2009-04-22 2010-11-11 Olympus Corp カテーテルおよび薬剤投与装置
EP2804603A1 (fr) 2012-01-10 2014-11-26 President and Fellows of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells

Also Published As

Publication number Publication date
FI916066A7 (fi) 1991-12-20
JPH05500620A (ja) 1993-02-12
NO915074L (no) 1992-01-31
NO915074D0 (no) 1991-12-20
JP2738881B2 (ja) 1998-04-08
AU632827B2 (en) 1993-01-14
DE69001672T2 (de) 1993-12-23
KR0141583B1 (ko) 1998-06-15
WO1990015637A2 (fr) 1990-12-27
ES2058923T3 (es) 1994-11-01
FI916066A0 (fi) 1991-12-20
AU5856590A (en) 1991-01-08
ATE89485T1 (de) 1993-06-15
EP0478671A1 (fr) 1992-04-08
DE69001672D1 (de) 1993-06-24
WO1990015637A3 (fr) 1991-04-04
DK0478671T3 (da) 1993-10-18
CA2062746A1 (fr) 1990-12-22
CA2062746C (fr) 1999-02-02
EP0478671B1 (fr) 1993-05-19

Similar Documents

Publication Publication Date Title
US5106627A (en) Neurological therapy devices
US5156844A (en) Neurological therapy system
AU632827B2 (en) Neurological therapy system
CA1335715C (fr) Acheminement in vivo de neurotransmetteurs au moyen de cellules implantees encapsulees
Shain et al. Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies
CA2090719C (fr) Liberation in vivo de facteurs actifs par implants cellulaires de coculture
Winn et al. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats
HK1002406B (en) -i(in vivo) delivery of neurotransmitters by implanted, encapsulated cells
US5853385A (en) Encapsulated PC12 cell transplants for treatment of Parkinson's disease
JPH09508002A (ja) 遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル
JP2023052084A (ja) 神経組織ユニットおよび哺乳類の神経系への埋め込みのための該ユニットの使用
CA2090720C (fr) Systeme d'implant neural
Emerich et al. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents
Kim et al. A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain
DE69219606T2 (de) Verfahren zur herstellung von biologische-vertraeglichen kapseln, enthaltend zellen
US20010041174A1 (en) Use of implanted encapsulated cells expressing glutamate transporter proteins for the treatment of neurodegenerative diseases
CN101511303A (zh) 用于细胞移植的装置和方法